Global Tissue Banking Market Research and Analysis, 2015-2022
MARKET INSIGHTS
Tissue banks are used to collect the human tissues for the medial and research applications. Tissues banks stores tissues under cryogenic conditions and are further used in drug discovery and development, clinical trials, medical research etc. Human Tissues are widely used in the treatment of the damaged heart muscles, spinal cord injuries. Advancements in the treatment of cell and tissue disorders has created many prospects for tissue banking. Therefore there is huge scope for the growth of the market. The global tissue banking market is anticipated to grow at the CAGR of 11.2% during the period 2017-2022. Increasing demand of the regenerative medicines and advancements in the tissue preservation and in-house sample testing are estimated to augment the growth of the market. Moreover, increasing number of bio banks across the globe, advancements in the medical drug discovery and biopharmaceuticals industry and advancements in the treatment of tissue disorders and cells are also estimated to fuel the growth of the market during the forecast period.
However, there are certain factors that are hindering the growth of the market. Storage and stability issues associated with the tissues and high cost of equipments are estimated to be the major constraints in the growth of the market. Except these restraints, tissue banking market is yet to explore its full potential in the market. Adoption of the advanced cosmetics surgeries and emergence of the automated tissue banking market is estimated to develop numerous expansion opportunities for the growth of the market.
The global tissue banking market is analyzed on the basis of the products, services and applications. On the basis of the product, market is segmented into equipments, accessories, consumables and media. Equipment market is further divided into freezers, storage systems, thawing equipments, labelling and coding equipments and alarming and monitoring equipments. Further, on the basis of the applications, our market is segmented into bio banking, drug discovery, regenerative medicines, therapeutics and others. And on the basis of the services, our market is bifurcated into processing, quarantine storage, screening, testing, tissue retrieval, screening and others.
GEOGRAPHY INSIGHTS
On the basis of the geography, the global tissue banking market is segmented into North America, Asia Pacific, Europe and Rest of the World. North America is estimated to be the leading region in the global tissue banking market. Presence of large number of bio banks that provides tissue samples for therapeutic and research purposes are estimated to be the major factor that is backing the growth of the market. Asia Pacific is estimated to be the fastest growing region during the forecast period owing to increasing biopharmaceuticals market and increasing number of bio banks in the region.
COMPETITIVE INSIGHTS
Key vendors of the tissue banking market are ABD Serotec, AMS Biotechnology Ltd., Beckman Coulter Inc., Biocision LLC., BioKryo, Biostorage Technologies Inc., Chernobyl Tissue Bank, Custom Biogenic Systems, EMD Millipore Corporation, EPL Archives, Eppendorf AG, Fisher Bioscience Inc., Genzyme Corporation, Organ Recovery Systems Inc., Panasonic Biomedical Sales Europe B.V., Sigma Aldrich Corporation, Taylor-Wharton International LLC., Tecan Group, Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc. and so on. In order to sustain in the market these players adopt various strategies such as mergers, acquisitions, product lunch and geographical expansion. For example: in 2016, Thermo Fisher announced the acquisition of the Affymetric Inc. in a $1.3 billion deal to strengthen its position in the market.
MARKET SEGMENTATION
4.1. GLOBAL TISSUE BANKING MARKET BY PRODUCTS
4.1.1. EQUIPMENT
4.1.1.1. FREEZERS
4.1.1.2. STORAGE SYSTEMS
4.1.1.3. THAWING EQUIPMENT
4.1.1.4. LABELLING AND CODING EQUIPMENT
4.1.1.5. ALARMING AND MONITORING EQUIPMENT
4.1.2. CONSUMABLES
4.1.3. MEDIA
4.1.4. ACCESSORIES
4.2. GLOBAL TISSUE BANKING MARKET BY SERVICES
4.2.1. PROCESSING
4.2.2. QUARANTINE STORAGE
4.2.3. SCREENING
4.2.4. TESTING
4.2.5. TISSUE RETRIEVAL
4.2.6. SCREENING
4.2.7. OTHERS
4.3. GLOBAL TISSUE BANKING MARKET BY APPLICATIONS
4.3.1. BIO BANKING
4.3.2. DRUG DISCOVERY
4.3.3. REGENERATIVE MEDICINES
4.3.4. THERAPEUTICS
4.3.5. OTHERS
OMR REPORT COVERS:
Tissue banks are used to collect the human tissues for the medial and research applications. Tissues banks stores tissues under cryogenic conditions and are further used in drug discovery and development, clinical trials, medical research etc. Human Tissues are widely used in the treatment of the damaged heart muscles, spinal cord injuries. Advancements in the treatment of cell and tissue disorders has created many prospects for tissue banking. Therefore there is huge scope for the growth of the market. The global tissue banking market is anticipated to grow at the CAGR of 11.2% during the period 2017-2022. Increasing demand of the regenerative medicines and advancements in the tissue preservation and in-house sample testing are estimated to augment the growth of the market. Moreover, increasing number of bio banks across the globe, advancements in the medical drug discovery and biopharmaceuticals industry and advancements in the treatment of tissue disorders and cells are also estimated to fuel the growth of the market during the forecast period.
However, there are certain factors that are hindering the growth of the market. Storage and stability issues associated with the tissues and high cost of equipments are estimated to be the major constraints in the growth of the market. Except these restraints, tissue banking market is yet to explore its full potential in the market. Adoption of the advanced cosmetics surgeries and emergence of the automated tissue banking market is estimated to develop numerous expansion opportunities for the growth of the market.
The global tissue banking market is analyzed on the basis of the products, services and applications. On the basis of the product, market is segmented into equipments, accessories, consumables and media. Equipment market is further divided into freezers, storage systems, thawing equipments, labelling and coding equipments and alarming and monitoring equipments. Further, on the basis of the applications, our market is segmented into bio banking, drug discovery, regenerative medicines, therapeutics and others. And on the basis of the services, our market is bifurcated into processing, quarantine storage, screening, testing, tissue retrieval, screening and others.
GEOGRAPHY INSIGHTS
On the basis of the geography, the global tissue banking market is segmented into North America, Asia Pacific, Europe and Rest of the World. North America is estimated to be the leading region in the global tissue banking market. Presence of large number of bio banks that provides tissue samples for therapeutic and research purposes are estimated to be the major factor that is backing the growth of the market. Asia Pacific is estimated to be the fastest growing region during the forecast period owing to increasing biopharmaceuticals market and increasing number of bio banks in the region.
COMPETITIVE INSIGHTS
Key vendors of the tissue banking market are ABD Serotec, AMS Biotechnology Ltd., Beckman Coulter Inc., Biocision LLC., BioKryo, Biostorage Technologies Inc., Chernobyl Tissue Bank, Custom Biogenic Systems, EMD Millipore Corporation, EPL Archives, Eppendorf AG, Fisher Bioscience Inc., Genzyme Corporation, Organ Recovery Systems Inc., Panasonic Biomedical Sales Europe B.V., Sigma Aldrich Corporation, Taylor-Wharton International LLC., Tecan Group, Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc. and so on. In order to sustain in the market these players adopt various strategies such as mergers, acquisitions, product lunch and geographical expansion. For example: in 2016, Thermo Fisher announced the acquisition of the Affymetric Inc. in a $1.3 billion deal to strengthen its position in the market.
MARKET SEGMENTATION
4.1. GLOBAL TISSUE BANKING MARKET BY PRODUCTS
4.1.1. EQUIPMENT
4.1.1.1. FREEZERS
4.1.1.2. STORAGE SYSTEMS
4.1.1.3. THAWING EQUIPMENT
4.1.1.4. LABELLING AND CODING EQUIPMENT
4.1.1.5. ALARMING AND MONITORING EQUIPMENT
4.1.2. CONSUMABLES
4.1.3. MEDIA
4.1.4. ACCESSORIES
4.2. GLOBAL TISSUE BANKING MARKET BY SERVICES
4.2.1. PROCESSING
4.2.2. QUARANTINE STORAGE
4.2.3. SCREENING
4.2.4. TESTING
4.2.5. TISSUE RETRIEVAL
4.2.6. SCREENING
4.2.7. OTHERS
4.3. GLOBAL TISSUE BANKING MARKET BY APPLICATIONS
4.3.1. BIO BANKING
4.3.2. DRUG DISCOVERY
4.3.3. REGENERATIVE MEDICINES
4.3.4. THERAPEUTICS
4.3.5. OTHERS
OMR REPORT COVERS:
- Comprehensive research methodology of Global Tissue Banking Market
- This report also includes detailed and extensive market overview with Analyst insights & key market trends.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Global Tissue Banking Market
- Insights about market determinants which are stimulating the Global Tissue Banking Market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1. UNITED STATES
2.3.2. EUROPEAN UNION
2.3.3. CHINA
2.3.4. INDIA
2.3.5. REST OF THE WORLD
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING DEMAND OF THE REGENERATIVE MEDICINES
3.1.2. ADVANCEMENT IN THE TISSUE PRESERVATION AND IN-HOUSE SAMPLE TESTING
3.1.3. RISING BIO BANKS
3.1.4. ADVANCEMENTS IN MEDICAL DRUG DISCOVERY AND BIOPHARMACEUTICALS INDUSTRY
3.1.5. ADVANCEMENTS IN THE TREATMENT OF TISSUE DISORDERS AND CELLS.
3.2. RESTRAINTS
3.2.1. STABILITY AND STORAGE OF TISSUES
3.2.2. HIGH COST OF EQUIPMENT
3.3. OPPORTUNITIES
3.3.1. EMERGENCE OF AUTOMATED TISSUE BANKING
3.3.2. ADOPTION OF ADVANCED COSMETIC SURGERIES
4. MARKET SEGMENTATION
4.1. GLOBAL TISSUE BANKING MARKET BY PRODUCTS
4.1.1. EQUIPMENT
4.1.1.1. FREEZERS
4.1.1.2. STORAGE SYSTEMS
4.1.1.3. THAWING EQUIPMENT
4.1.1.4. LABELLING AND CODING EQUIPMENT
4.1.1.5. ALARMING AND MONITORING EQUIPMENT
4.1.2. CONSUMABLES
4.1.3. MEDIA
4.1.4. ACCESSORIES
4.2. GLOBAL TISSUE BANKING MARKET BY SERVICES
4.2.1. PROCESSING
4.2.2. QUARANTINE STORAGE
4.2.3. SCREENING
4.2.4. TESTING
4.2.5. TISSUE RETRIEVAL
4.2.6. SCREENING
4.2.7. OTHERS
4.3. GLOBAL TISSUE BANKING MARKET BY APPLICATIONS
4.3.1. BIO BANKING
4.3.2. DRUG DISCOVERY
4.3.3. REGENERATIVE MEDICINES
4.3.4. THERAPEUTICS
4.3.5. OTHERS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGY ANALYSIS
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.1.3. REST OF NORTH AMERICA
6.2. EUROPE
6.2.1. UNITED KINGDOM
6.2.2. FRANCE
6.2.3. GERMANY
6.2.4. ITALY
6.2.5. SPAIN
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. ABD SEROTEC
7.1.1. INTRODUCTION
7.1.2. ABD SEROTEC PRODUCT PORTFOLIO
7.1.3. ABD SEROTEC RECENT ACTIVITIES
7.2. AMS BIOTECHNOLOGY LTD.
7.2.1. INTRODUCTION
7.2.2. AMS BIOTECHNOLOGY LTD. PRODUCT PORTFOLIO
7.2.3. AMS BIOTECHNOLOGY LTD. RECENT ACTIVITIES
7.3. BECKMAN COULTER INC.
7.3.1. INTRODUCTION
7.3.2. BECKMAN COULTER INC. PRODUCT PORTFOLIO
7.3.3. BECKMAN COULTER INC. RECENT ACTIVITIES
7.4. BIOCISION LLC.
7.4.1. INTRODUCTION
7.4.2. BIOCISION LLC. PRODUCT PORTFOLIO
7.4.3. BIOCISION LLC. RECENT ACTIVITIES
7.5. BIOKYRO
7.5.1. INTRODUCTION
7.5.2. BIOKYRO PRODUCT PORTFOLIO
7.5.3. BIOKYRO RECENT ACTIVITIES
7.6. BIOSTORAGE TECHNOLOGIES INC.
7.6.1. INTRODUCTION
7.6.2. BIOSTORAGE TECHNOLOGIES INC. PRODUCT PORTFOLIO
7.6.3. BIOSTORAGE TECHNOLOGIES INC. RECENT ACTIVITIES
7.7. CHERNOBYL TISSUE BANK
7.7.1. INTRODUCTION
7.7.2. CHERNOBYL TISSUE BANK PRODUCT PORTFOLIO
7.7.3. CHERNOBYL TISSUE BANK RECENT ACTIVITIES
7.8. CUSTOM BIOGENIC SYSTEMS
7.8.1. INTRODUCTION
7.8.2. CUSTOM BIOGENIC SYSTEMS PRODUCT PORTFOLIO
7.8.3. CUSTOM BIOGENIC SYSTEMS RECENT ACTIVITIES
7.9. EMD ARCHIVES
7.9.1. INTRODUCTION
7.9.2. EMD ARCHIVES PRODUCT PORTFOLIO
7.9.3. EMD ARCHIVES RECENT ACTIVITIES
7.10. EPL ARCHIVES
7.10.1. INTRODUCTION
7.10.2. EPL ARCHIVES PRODUCT PORTFOLIO
7.10.3. EPL ARCHIVES RECENT ACTIVITIES
7.11. EPPENDROF AG
7.11.1. INTRODUCTION
7.11.2. EPPENDROF AG PRODUCT PORTFOLIO
7.11.3. EPPENDROF AG RECENT ACTIVITIES
7.12. FISHER BIOSCIENCE INC.
7.12.1. INTRODUCTION
7.12.2. FISHER BIOSCIENCE INC. PRODUCT PORTFOLIO
7.12.3. FISHER BIOSCIENCE INC. RECENT ACTIVITIES
7.13. GENZYME CORPORATION
7.13.1. INTRODUCTION
7.13.2. GENZYME CORPORATION PRODUCT PORTFOLIO
7.13.3. GENZYME CORPORATION RECENT ACTIVITIES
7.14. ORGAN RECOVERY SYSTEMS INC.
7.14.1. INTRODUCTION
7.14.2. ORGAN RECOVERY SYSTEMS INC. PRODUCT PORTFOLIO
7.14.3. ORGAN RECOVERY SYSTEMS INC. RECENT ACTIVITIES
7.15. PANASONIC BIOMEDICAL SALES EUROPE B.V.
7.15.1. INTRODUCTION
7.15.2. PANASONIC BIOMEDICAL SALES EUROPE B.V. PRODUCT PORTFOLIO
7.15.3. PANASONIC BIOMEDICAL SALES EUROPE B.V. RECENT ACTIVITIES
7.16. SIGMA ALDRICH CORPORATION
7.16.1. INTRODUCTION
7.16.2. SIGMA ALDRICH CORPORATION PRODUCT PORTFOLIO
7.16.3. SIGMA ALDRICH CORPORATION RECENT ACTIVITIES
7.17. TAYLOR WHARTON INTERNATIONAL LLC.
7.17.1. INTRODUCTION
7.17.2. TAYLOR WHARTON INTERNATIONAL LLC. PRODUCT PORTFOLIO
7.17.3. TAYLOR WHARTON INTERNATIONAL LLC. RECENT ACTIVITIES
7.18. TECAN GROUP
7.18.1. INTRODUCTION
7.18.2. TECAN GROUP PRODUCT PORTFOLIO
7.18.3. TECAN GROUP RECENT ACTIVITIES
7.19. TEVA PHARMACEUTICALS INDUSTRIES LTD.
7.19.1. INTRODUCTION
7.19.2. TEVA PHARMACEUTICALS INDUSTRIES LTD. PRODUCT PORTFOLIO
7.19.3. TEVA PHARMACEUTICALS INDUSTRIES LTD. RECENT ACTIVITIES
7.20. THERMOFISHER SCIENTIFIC INC.
7.20.1. INTRODUCTION
7.20.2. THERMOFISHER SCIENTIFIC INC. PRODUCT PORTFOLIO
7.20.3. THERMOFISHER SCIENTIFIC INC. RECENT ACTIVITIES
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1. UNITED STATES
2.3.2. EUROPEAN UNION
2.3.3. CHINA
2.3.4. INDIA
2.3.5. REST OF THE WORLD
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING DEMAND OF THE REGENERATIVE MEDICINES
3.1.2. ADVANCEMENT IN THE TISSUE PRESERVATION AND IN-HOUSE SAMPLE TESTING
3.1.3. RISING BIO BANKS
3.1.4. ADVANCEMENTS IN MEDICAL DRUG DISCOVERY AND BIOPHARMACEUTICALS INDUSTRY
3.1.5. ADVANCEMENTS IN THE TREATMENT OF TISSUE DISORDERS AND CELLS.
3.2. RESTRAINTS
3.2.1. STABILITY AND STORAGE OF TISSUES
3.2.2. HIGH COST OF EQUIPMENT
3.3. OPPORTUNITIES
3.3.1. EMERGENCE OF AUTOMATED TISSUE BANKING
3.3.2. ADOPTION OF ADVANCED COSMETIC SURGERIES
4. MARKET SEGMENTATION
4.1. GLOBAL TISSUE BANKING MARKET BY PRODUCTS
4.1.1. EQUIPMENT
4.1.1.1. FREEZERS
4.1.1.2. STORAGE SYSTEMS
4.1.1.3. THAWING EQUIPMENT
4.1.1.4. LABELLING AND CODING EQUIPMENT
4.1.1.5. ALARMING AND MONITORING EQUIPMENT
4.1.2. CONSUMABLES
4.1.3. MEDIA
4.1.4. ACCESSORIES
4.2. GLOBAL TISSUE BANKING MARKET BY SERVICES
4.2.1. PROCESSING
4.2.2. QUARANTINE STORAGE
4.2.3. SCREENING
4.2.4. TESTING
4.2.5. TISSUE RETRIEVAL
4.2.6. SCREENING
4.2.7. OTHERS
4.3. GLOBAL TISSUE BANKING MARKET BY APPLICATIONS
4.3.1. BIO BANKING
4.3.2. DRUG DISCOVERY
4.3.3. REGENERATIVE MEDICINES
4.3.4. THERAPEUTICS
4.3.5. OTHERS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGY ANALYSIS
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.1.3. REST OF NORTH AMERICA
6.2. EUROPE
6.2.1. UNITED KINGDOM
6.2.2. FRANCE
6.2.3. GERMANY
6.2.4. ITALY
6.2.5. SPAIN
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. ABD SEROTEC
7.1.1. INTRODUCTION
7.1.2. ABD SEROTEC PRODUCT PORTFOLIO
7.1.3. ABD SEROTEC RECENT ACTIVITIES
7.2. AMS BIOTECHNOLOGY LTD.
7.2.1. INTRODUCTION
7.2.2. AMS BIOTECHNOLOGY LTD. PRODUCT PORTFOLIO
7.2.3. AMS BIOTECHNOLOGY LTD. RECENT ACTIVITIES
7.3. BECKMAN COULTER INC.
7.3.1. INTRODUCTION
7.3.2. BECKMAN COULTER INC. PRODUCT PORTFOLIO
7.3.3. BECKMAN COULTER INC. RECENT ACTIVITIES
7.4. BIOCISION LLC.
7.4.1. INTRODUCTION
7.4.2. BIOCISION LLC. PRODUCT PORTFOLIO
7.4.3. BIOCISION LLC. RECENT ACTIVITIES
7.5. BIOKYRO
7.5.1. INTRODUCTION
7.5.2. BIOKYRO PRODUCT PORTFOLIO
7.5.3. BIOKYRO RECENT ACTIVITIES
7.6. BIOSTORAGE TECHNOLOGIES INC.
7.6.1. INTRODUCTION
7.6.2. BIOSTORAGE TECHNOLOGIES INC. PRODUCT PORTFOLIO
7.6.3. BIOSTORAGE TECHNOLOGIES INC. RECENT ACTIVITIES
7.7. CHERNOBYL TISSUE BANK
7.7.1. INTRODUCTION
7.7.2. CHERNOBYL TISSUE BANK PRODUCT PORTFOLIO
7.7.3. CHERNOBYL TISSUE BANK RECENT ACTIVITIES
7.8. CUSTOM BIOGENIC SYSTEMS
7.8.1. INTRODUCTION
7.8.2. CUSTOM BIOGENIC SYSTEMS PRODUCT PORTFOLIO
7.8.3. CUSTOM BIOGENIC SYSTEMS RECENT ACTIVITIES
7.9. EMD ARCHIVES
7.9.1. INTRODUCTION
7.9.2. EMD ARCHIVES PRODUCT PORTFOLIO
7.9.3. EMD ARCHIVES RECENT ACTIVITIES
7.10. EPL ARCHIVES
7.10.1. INTRODUCTION
7.10.2. EPL ARCHIVES PRODUCT PORTFOLIO
7.10.3. EPL ARCHIVES RECENT ACTIVITIES
7.11. EPPENDROF AG
7.11.1. INTRODUCTION
7.11.2. EPPENDROF AG PRODUCT PORTFOLIO
7.11.3. EPPENDROF AG RECENT ACTIVITIES
7.12. FISHER BIOSCIENCE INC.
7.12.1. INTRODUCTION
7.12.2. FISHER BIOSCIENCE INC. PRODUCT PORTFOLIO
7.12.3. FISHER BIOSCIENCE INC. RECENT ACTIVITIES
7.13. GENZYME CORPORATION
7.13.1. INTRODUCTION
7.13.2. GENZYME CORPORATION PRODUCT PORTFOLIO
7.13.3. GENZYME CORPORATION RECENT ACTIVITIES
7.14. ORGAN RECOVERY SYSTEMS INC.
7.14.1. INTRODUCTION
7.14.2. ORGAN RECOVERY SYSTEMS INC. PRODUCT PORTFOLIO
7.14.3. ORGAN RECOVERY SYSTEMS INC. RECENT ACTIVITIES
7.15. PANASONIC BIOMEDICAL SALES EUROPE B.V.
7.15.1. INTRODUCTION
7.15.2. PANASONIC BIOMEDICAL SALES EUROPE B.V. PRODUCT PORTFOLIO
7.15.3. PANASONIC BIOMEDICAL SALES EUROPE B.V. RECENT ACTIVITIES
7.16. SIGMA ALDRICH CORPORATION
7.16.1. INTRODUCTION
7.16.2. SIGMA ALDRICH CORPORATION PRODUCT PORTFOLIO
7.16.3. SIGMA ALDRICH CORPORATION RECENT ACTIVITIES
7.17. TAYLOR WHARTON INTERNATIONAL LLC.
7.17.1. INTRODUCTION
7.17.2. TAYLOR WHARTON INTERNATIONAL LLC. PRODUCT PORTFOLIO
7.17.3. TAYLOR WHARTON INTERNATIONAL LLC. RECENT ACTIVITIES
7.18. TECAN GROUP
7.18.1. INTRODUCTION
7.18.2. TECAN GROUP PRODUCT PORTFOLIO
7.18.3. TECAN GROUP RECENT ACTIVITIES
7.19. TEVA PHARMACEUTICALS INDUSTRIES LTD.
7.19.1. INTRODUCTION
7.19.2. TEVA PHARMACEUTICALS INDUSTRIES LTD. PRODUCT PORTFOLIO
7.19.3. TEVA PHARMACEUTICALS INDUSTRIES LTD. RECENT ACTIVITIES
7.20. THERMOFISHER SCIENTIFIC INC.
7.20.1. INTRODUCTION
7.20.2. THERMOFISHER SCIENTIFIC INC. PRODUCT PORTFOLIO
7.20.3. THERMOFISHER SCIENTIFIC INC. RECENT ACTIVITIES
LIST OF TABLES
TABLE #1 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY PRODUCTS 2015-2022 ($ MILLION)
TABLE #2 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY EQUIPMENT 2015-2022 ($ MILLION)
TABLE #3 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY FREEZERS 2015-2022 ($ MILLION)
TABLE #4 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY STORAGE SYSTEMS 2015-2022 ($ MILLION)
TABLE #5 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY THAWING EQUIPMENT 2015-2022 ($ MILLION)
TABLE #6 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY LABELLING AND CODING EQUIPMENT 2015-2022 ($ MILLION)
TABLE #7 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY ALARMING AND MONITORING EQUIPMENT 2015-2022 ($ MILLION)
TABLE #8 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY CONSUMABLES 2015-2022 ($ MILLION)
TABLE #9 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY MEDIA 2015-2022 ($ MILLION)
TABLE #10 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY ACCESSORIES 2015-2022 ($ MILLION)
TABLE #11 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY SERVICES 2015-2022 ($ MILLION)
TABLE #12 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY SCREENING 2015-2022 ($ MILLION)
TABLE #13 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY TISSUE RETRIEVAL 2015-2022 ($ MILLION)
TABLE #14 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY TESTING 2015-2022 ($ MILLION)
TABLE #15 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY PROCESSING ($ MILLION)
TABLE #16 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY QUARANTINE STORAGE 2015-2022 ($ MILLION)
TABLE #17 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY OTHER SERVICES 2015-2022 ($ MILLION)
TABLE #18 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2015-2022 ($ MILLION)
TABLE #19 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY BIO BANKING 2015-2022 ($ MILLION)
TABLE #20 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY REGENERATIVE MEDICINES 2015-2022 ($ MILLION)
TABLE #21 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY DRUG DISCOVERY 2015-2022 ($ MILLION)
TABLE #22 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY THERAPEUTICS 2015-2022 ($ MILLION)
TABLE #23 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY OTHERS 2015-2022 ($ MILLION)
TABLE #24 ABD SEROTEC PRODUCT PORTFOLIO
TABLE #25 ABD SEROTEC RECENT ACTIVITIES
TABLE #26 AMS BIOTECHNOLOGY LTD. PRODUCT PORTFOLIO
TABLE #27 AMS BIOTECHNOLOGY LTD. RECENT ACTIVITIES
TABLE #28 BECKMAN COULTER INC. PRODUCT PORTFOLIO
TABLE #29 BECKMAN COULTER INC. RECENT ACTIVITIES
TABLE #30 BIOCISION LLC. PRODUCT PORTFOLIO
TABLE #31 BIOCISION LLC. RECENT ACTIVITIES
TABLE #32 BIOKYRO PRODUCT PORTFOLIO
TABLE #33 BIOKYRO RECENT ACTIVITIES
TABLE #34 BIOSTORAGE TECHNOLOGIES INC. PRODUCT PORTFOLIO
TABLE #35 BIOSTORAGE TECHNOLOGIES INC. RECENT ACTIVITIES
TABLE #36 CHERNOBYL TISSUE BANK PRODUCT PORTFOLIO
TABLE #37 CHERNOBYL TISSUE BANK RECENT ACTIVITIES
TABLE #38 CUSTOM BIOGENIC SYSTEMS PRODUCT PORTFOLIO
TABLE #39 CUSTOM BIOGENIC SYSTEMS RECENT ACTIVITIES
TABLE #40 EMD ARCHIVES PRODUCT PORTFOLIO
TABLE #41 EMD ARCHIVES RECENT ACTIVITIES
TABLE #42 EPL ARCHIVES PRODUCT PORTFOLIO
TABLE #43 EPL ARCHIVES RECENT ACTIVITIES
TABLE #44 EPPENDROF AG PRODUCT PORTFOLIO
TABLE #45 EPPENDROF AG RECENT ACTIVITIES
TABLE #46 FISHER BIOSCIENCE INC. PRODUCT PORTFOLIO
TABLE #47 FISHER BIOSCIENCE INC. RECENT ACTIVITIES
TABLE #48 GENZYME CORPORATION PRODUCT PORTFOLIO
TABLE #49 GENZYME CORPORATION RECENT ACTIVITIES
TABLE #50 ORGAN RECOVERY SYSTEMS INC. PRODUCT PORTFOLIO
TABLE #51 ORGAN RECOVERY SYSTEMS INC. RECENT ACTIVITIES
TABLE #52 PANASONIC BIOMEDICAL SALES EUROPE B.V. PRODUCT PORTFOLIO
TABLE #53 PANASONIC BIOMEDICAL SALES EUROPE B.V. RECENT ACTIVITIES
TABLE #54 SIGMA ALDRICH CORPORATION PRODUCT PORTFOLIO
TABLE #55 SIGMA ALDRICH CORPORATION RECENT ACTIVITIES
TABLE #56 TAYLOR WHARTON INTERNATIONAL LLC. PRODUCT PORTFOLIO
TABLE #57 TAYLOR WHARTON INTERNATIONAL LLC. RECENT ACTIVITIES
TABLE #58 TECAN GROUP PRODUCT PORTFOLIO
TABLE #59 TECAN GROUP RECENT ACTIVITIES
TABLE #60 TEVA PHARMACEUTICALS INDUSTRIES LTD. PRODUCT PORTFOLIO
TABLE #61 TEVA PHARMACEUTICALS INDUSTRIES LTD. RECENT ACTIVITIES
TABLE #62 THERMOFISHER SCIENTIFIC INC. PRODUCT PORTFOLIO
TABLE #63 THERMOFISHER SCIENTIFIC INC. RECENT ACTIVITIES
TABLE #1 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY PRODUCTS 2015-2022 ($ MILLION)
TABLE #2 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY EQUIPMENT 2015-2022 ($ MILLION)
TABLE #3 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY FREEZERS 2015-2022 ($ MILLION)
TABLE #4 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY STORAGE SYSTEMS 2015-2022 ($ MILLION)
TABLE #5 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY THAWING EQUIPMENT 2015-2022 ($ MILLION)
TABLE #6 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY LABELLING AND CODING EQUIPMENT 2015-2022 ($ MILLION)
TABLE #7 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY ALARMING AND MONITORING EQUIPMENT 2015-2022 ($ MILLION)
TABLE #8 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY CONSUMABLES 2015-2022 ($ MILLION)
TABLE #9 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY MEDIA 2015-2022 ($ MILLION)
TABLE #10 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY ACCESSORIES 2015-2022 ($ MILLION)
TABLE #11 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY SERVICES 2015-2022 ($ MILLION)
TABLE #12 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY SCREENING 2015-2022 ($ MILLION)
TABLE #13 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY TISSUE RETRIEVAL 2015-2022 ($ MILLION)
TABLE #14 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY TESTING 2015-2022 ($ MILLION)
TABLE #15 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY PROCESSING ($ MILLION)
TABLE #16 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY QUARANTINE STORAGE 2015-2022 ($ MILLION)
TABLE #17 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY OTHER SERVICES 2015-2022 ($ MILLION)
TABLE #18 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2015-2022 ($ MILLION)
TABLE #19 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY BIO BANKING 2015-2022 ($ MILLION)
TABLE #20 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY REGENERATIVE MEDICINES 2015-2022 ($ MILLION)
TABLE #21 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY DRUG DISCOVERY 2015-2022 ($ MILLION)
TABLE #22 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY THERAPEUTICS 2015-2022 ($ MILLION)
TABLE #23 GLOBAL TISSUE BANKING MARKET RESEARCH AND ANALYSIS, BY OTHERS 2015-2022 ($ MILLION)
TABLE #24 ABD SEROTEC PRODUCT PORTFOLIO
TABLE #25 ABD SEROTEC RECENT ACTIVITIES
TABLE #26 AMS BIOTECHNOLOGY LTD. PRODUCT PORTFOLIO
TABLE #27 AMS BIOTECHNOLOGY LTD. RECENT ACTIVITIES
TABLE #28 BECKMAN COULTER INC. PRODUCT PORTFOLIO
TABLE #29 BECKMAN COULTER INC. RECENT ACTIVITIES
TABLE #30 BIOCISION LLC. PRODUCT PORTFOLIO
TABLE #31 BIOCISION LLC. RECENT ACTIVITIES
TABLE #32 BIOKYRO PRODUCT PORTFOLIO
TABLE #33 BIOKYRO RECENT ACTIVITIES
TABLE #34 BIOSTORAGE TECHNOLOGIES INC. PRODUCT PORTFOLIO
TABLE #35 BIOSTORAGE TECHNOLOGIES INC. RECENT ACTIVITIES
TABLE #36 CHERNOBYL TISSUE BANK PRODUCT PORTFOLIO
TABLE #37 CHERNOBYL TISSUE BANK RECENT ACTIVITIES
TABLE #38 CUSTOM BIOGENIC SYSTEMS PRODUCT PORTFOLIO
TABLE #39 CUSTOM BIOGENIC SYSTEMS RECENT ACTIVITIES
TABLE #40 EMD ARCHIVES PRODUCT PORTFOLIO
TABLE #41 EMD ARCHIVES RECENT ACTIVITIES
TABLE #42 EPL ARCHIVES PRODUCT PORTFOLIO
TABLE #43 EPL ARCHIVES RECENT ACTIVITIES
TABLE #44 EPPENDROF AG PRODUCT PORTFOLIO
TABLE #45 EPPENDROF AG RECENT ACTIVITIES
TABLE #46 FISHER BIOSCIENCE INC. PRODUCT PORTFOLIO
TABLE #47 FISHER BIOSCIENCE INC. RECENT ACTIVITIES
TABLE #48 GENZYME CORPORATION PRODUCT PORTFOLIO
TABLE #49 GENZYME CORPORATION RECENT ACTIVITIES
TABLE #50 ORGAN RECOVERY SYSTEMS INC. PRODUCT PORTFOLIO
TABLE #51 ORGAN RECOVERY SYSTEMS INC. RECENT ACTIVITIES
TABLE #52 PANASONIC BIOMEDICAL SALES EUROPE B.V. PRODUCT PORTFOLIO
TABLE #53 PANASONIC BIOMEDICAL SALES EUROPE B.V. RECENT ACTIVITIES
TABLE #54 SIGMA ALDRICH CORPORATION PRODUCT PORTFOLIO
TABLE #55 SIGMA ALDRICH CORPORATION RECENT ACTIVITIES
TABLE #56 TAYLOR WHARTON INTERNATIONAL LLC. PRODUCT PORTFOLIO
TABLE #57 TAYLOR WHARTON INTERNATIONAL LLC. RECENT ACTIVITIES
TABLE #58 TECAN GROUP PRODUCT PORTFOLIO
TABLE #59 TECAN GROUP RECENT ACTIVITIES
TABLE #60 TEVA PHARMACEUTICALS INDUSTRIES LTD. PRODUCT PORTFOLIO
TABLE #61 TEVA PHARMACEUTICALS INDUSTRIES LTD. RECENT ACTIVITIES
TABLE #62 THERMOFISHER SCIENTIFIC INC. PRODUCT PORTFOLIO
TABLE #63 THERMOFISHER SCIENTIFIC INC. RECENT ACTIVITIES
LIST OF FIGURES
FIGURE #1 NORTH AMERICA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #2 US MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #5 UK MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #6 FRANCE MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #8 GERMANY MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #9 ITALY MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #10 SPAIN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #11 ROE MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #12 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #13 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #14 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #15 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #16 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #17 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2022
COMPANIES MENTIONED
1. ABD Serotec
2. AMS Biotechnology Ltd.
3. Beckman Coulter Inc.
4. Biocision LLC.
5. BioKryo
6. Biostorage Technologies Inc.
7. Chernobyl Tissue Bank
8. Custom Biogenic Systems
9. EMD Millipore Corporation
10. EPL Archives
11. Eppendorf AG
12. Fisher Bioscience Inc.
13. Genzyme Corporation
14. Organ Recovery Systems Inc.
15. Panasonic Biomedical Sales Europe B.V.
16. Sigma Aldrich Corporation
17. Taylor-Wharton International LLC.
18. Tecan Group
19. Teva Pharmaceutical Industries Ltd.
20. Thermo Fisher Scientific Inc.
FIGURE #1 NORTH AMERICA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #2 US MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #5 UK MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #6 FRANCE MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #8 GERMANY MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #9 ITALY MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #10 SPAIN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #11 ROE MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #12 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #13 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #14 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #15 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #16 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #17 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2022
COMPANIES MENTIONED
1. ABD Serotec
2. AMS Biotechnology Ltd.
3. Beckman Coulter Inc.
4. Biocision LLC.
5. BioKryo
6. Biostorage Technologies Inc.
7. Chernobyl Tissue Bank
8. Custom Biogenic Systems
9. EMD Millipore Corporation
10. EPL Archives
11. Eppendorf AG
12. Fisher Bioscience Inc.
13. Genzyme Corporation
14. Organ Recovery Systems Inc.
15. Panasonic Biomedical Sales Europe B.V.
16. Sigma Aldrich Corporation
17. Taylor-Wharton International LLC.
18. Tecan Group
19. Teva Pharmaceutical Industries Ltd.
20. Thermo Fisher Scientific Inc.
